Research Areas

OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the largest cell and gene therapy hubs in the country.

Dehydrodolichyl diphosphate synthase (DHDSS)-related disease has no available treatments. The new work could finally change that with  nicotinamide mononucleotide (NMN).

Sessions spanning chemoproteomics, AI-driven proteomics, biotherapeutic characterization, single-cell omics, and spatial multiomics all pointed toward mass spectrometry’s growing role in drug discovery and development.

Explore key considerations for improving molecular biology workflows through centralized design, data management, and collaborative research practices.

The fully-automated system can complete a full drug discovery cycle in a matter of hours rather than weeks.

New instrument launches from two major vendors at this year's conference reflected shared priorities: higher proteome coverage, richer characterization of complex biotherapeutics, and tighter integration of AI. 

Advanced mass spectrometry and multidimensional separation strategies are improving the characterization of proteins, peptides, and complex biotherapeutics.

By stabilizing G-quadruplex DNA, a revived anticancer drug offers a new way to shut down a key oncogene.

Some people with amyloid plaques and tau tangles in their brain never develop Alzheimer’s disease. New research suggests it comes down to microglial activity.

Gene therapies dominated the news this week, with positive results for both a CRISPR and non-viral therapy, and a U-turn decision from the FDA.